Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation ; volume:145 ; number:1 ; day:16 ; month:11 ; year:2022 ; pages:13-28 ; date:1.2023
Acta neuropathologica ; 145, Heft 1 (16.11.2022), 13-28, 1.2023
- Creator
-
Forsberg, Karin M.
Graffmo, Karin S.
Stenvall, Erica
Tabikh, Naima
Marklund, Stefan L.
Brännström, Thomas
Andersen, Peter M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-022-02519-z
- URN
-
urn:nbn:de:101:1-2023031209263143293763
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Forsberg, Karin M.
- Graffmo, Karin S.
- Stenvall, Erica
- Tabikh, Naima
- Marklund, Stefan L.
- Brännström, Thomas
- Andersen, Peter M.
- SpringerLink (Online service)
Other Objects (12)
Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity
Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity
Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes
Cellular analysis of SOD1 protein-aggregation propensity and toxicity: a case of ALS with slow progression harboring homozygous SOD1-D92G mutation
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity
Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications